Unitree Robotics Shanghai IPO Valuation and Market Impact

Unitree Robotics has secured approval from China’s securities regulator to proceed with an IPO on the Shanghai STAR Market, a move that establishes the first public valuation benchmark for the global humanoid robot sector [1]. The offering, which aims to raise approximately 4.2 billion yuan ($618 million), provides the market with its first look at the financials of a profitable, high-volume humanoid manufacturer [2].

A new benchmark for humanoid robotics

The IPO filing reveals that Unitree, which shipped 5,500 humanoids in 2025, operates with gross margins near 60 percent and net margins in the mid-teens [2]. This performance stands in contrast to competitors like UBTech, which remains unprofitable despite a similar revenue scale [2]. By pricing the company at roughly 3.5 times its mid-2025 private valuation of $1.7 billion, the offering creates a concrete valuation multiple of approximately 25 times sales [2].

This public pricing forces a repricing of the broader humanoid narrative, where private valuations have historically been curated by companies rather than market forces [2]. While firms like Figure have maintained private valuations as high as $39 billion, those figures have lacked the daily price discovery that Unitree will now provide [2]. Investors who previously accessed the sector through indirect exposure to conglomerates or component suppliers will now have a direct instrument to track the industry’s commercial viability [2].

Market positioning and industry comps

Unitree’s path to the public market was the fastest in the history of the STAR Market, clearing review in just 104 days [2]. The company’s prospectus highlights a shift in its core business, with humanoids accounting for 52 percent of total revenue in 2025, overtaking its legacy robot dog products [2]. Despite the public listing, founder Wang Xingxing will retain control through Class A shares that carry 10 votes each [2].

The debut serves as a critical test for the "embodied AI" theme, as the market weighs Unitree’s profitable hardware model against the massive capital expenditures of competitors like Tesla [2]. While Tesla continues to scale its Optimus production, Unitree’s ability to extract high margins from hardware provides a validation of the category’s underlying economics [2]. However, the company’s stock performance will be subject to the same volatility seen in recent Chinese robotics listings, where initial enthusiasm often diverges from long-term valuation [2].

What to watch

• Debut Price Discovery: Monitor the stock’s trading range in the weeks following the listing to see if the 25x sales multiple holds or compresses as the initial IPO frenzy fades [2].
• Sector Valuation Ripple: Observe how private humanoid programs and related component suppliers adjust their internal valuations in response to the public benchmark set by Unitree [2].
• Production Scaling: Watch for updates on the manufacturing base expansion, which is a primary use case for the 4.2 billion yuan in proceeds [1].

The success of Unitree’s IPO will likely determine whether the market treats humanoid robotics as a sustainable, margin-positive industry or a speculative growth play. As the first profitable volume leader to go public, Unitree provides the "weighing machine" that will discipline the next wave of robot prospectuses [2].